NewEdge Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12
| Closed | -$18 | – | 3577 |
|
|
2023
Q1 | $18 | Hold |
12
| – | – | ﹤0.01% | 3388 |
|
|
2022
Q4 | $0 | Buy |
+12
| New | – | ﹤0.01% | 4162 |
|
|
2020
Q1 | – | Sell |
-10,000
| Closed | -$8K | – | 850 |
|
|
2019
Q4 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 813 |
|
|
2019
Q3 | $10K | Sell |
10,000
-7
| -0.1% | -$7 | ﹤0.01% | 810 |
|
|
2019
Q2 | $11K | Buy |
10,007
+7
| +0.1% | +$8 | ﹤0.01% | 653 |
|
|
2019
Q1 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 669 |
|
|
2018
Q4 | $9 | Sell |
10,000
-24,290
| -71% | -$22 | ﹤0.01% | 624 |
|
|
2018
Q3 | $71K | Buy |
34,290
+11,430
| +50% | +$23.7K | 0.01% | 642 |
|
|
2018
Q2 | $41 | Sell |
22,860
-5,410
| -19% | -$10 | ﹤0.01% | 537 |
|
|
2018
Q1 | $64K | Buy |
28,270
+10,771
| +62% | +$24.4K | 0.01% | 484 |
|
|
2017
Q4 | $42K | Buy |
+17,499
| New | +$42K | 0.01% | 405 |
|